cognitive cybersecurity intelligence

News and Analysis

Search

What to Know About Newly Approved Alzheimer’s Drug

Jan. 6, 2023 — The highly anticipated Alzheimer’s drug lecanemab was granted accelerated approval status this afternoon by the FDA, offering hope where there has been little for patients and their families affected by the devastating disease.More than 6 million people in the U.S. live with…

Source: www.webmd.comRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts